Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.
Publication
, Journal Article
Rao, VN; Fudim, M; Savarese, G; Butler, J
Published in: Am J Med
September 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Med
DOI
EISSN
1555-7162
Publication Date
September 2021
Volume
134
Issue
9
Start / End Page
1068 / 1070
Location
United States
Related Subject Headings
- Stroke Volume
- Risk Assessment
- Professional Practice Gaps
- Practice Guidelines as Topic
- Polypharmacy
- Polypharmacology
- Patient Selection
- Humans
- Heart Failure
- General & Internal Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, V. N., Fudim, M., Savarese, G., & Butler, J. (2021). Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem. Am J Med, 134(9), 1068–1070. https://doi.org/10.1016/j.amjmed.2021.03.038
Rao, Vishal N., Marat Fudim, Gianluigi Savarese, and Javed Butler. “Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.” Am J Med 134, no. 9 (September 2021): 1068–70. https://doi.org/10.1016/j.amjmed.2021.03.038.
Rao VN, Fudim M, Savarese G, Butler J. Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem. Am J Med. 2021 Sep;134(9):1068–70.
Rao, Vishal N., et al. “Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.” Am J Med, vol. 134, no. 9, Sept. 2021, pp. 1068–70. Pubmed, doi:10.1016/j.amjmed.2021.03.038.
Rao VN, Fudim M, Savarese G, Butler J. Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem. Am J Med. 2021 Sep;134(9):1068–1070.
Published In
Am J Med
DOI
EISSN
1555-7162
Publication Date
September 2021
Volume
134
Issue
9
Start / End Page
1068 / 1070
Location
United States
Related Subject Headings
- Stroke Volume
- Risk Assessment
- Professional Practice Gaps
- Practice Guidelines as Topic
- Polypharmacy
- Polypharmacology
- Patient Selection
- Humans
- Heart Failure
- General & Internal Medicine